Rituximab and intermediate‐purity plasma‐derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1101|30|1|50-54

ISSN： 0733-2459

Source： JOURNAL OF CLINICAL APHERESIS, Vol.30, Iss.1, 2015-02, pp. : 50-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 3, 2015-03 ,pp. : 380-389

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: reply

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1526-1527

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity: comment

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 8, 2015-08 ,pp. : 1524-1525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-04 ,pp. : 196-199

Karger

Access to resources Recommend Favorite

Response to Plasma Exchange and Steroids as Combined Therapy for Patients with Thrombotic Thrombocytopenic Purpura

By  

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 12-16

Karger

Access to resources Recommend Favorite